Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study

被引：1
|
作者：
Liu, Jessica [1 ]
Chin-Yee, Benjamin [2 ]
Chin-Yee, Ian H. [2 ,3 ]
Ho, Jenny [2 ]
Sadikovic, Bekim [3 ]
Hsia, Cyrus C. [2 ,4 ]
机构：
[1] London Hlth Sci Ctr, Dept Med, London, ON, Canada
[2] London Hlth Sci Ctr, Dept Med, Div Hematol, London, ON, Canada
[3] London Hlth Sci Ctr, Dept Pathol & Lab Med, London, ON, Canada
[4] Victoria Hosp, Room E6 219A,800 Commissioners Rd, London, ON N6A5W9, Canada
来源：
JOURNAL OF INTERNAL MEDICINE | 2024年 / 295卷 / 01期
关键词：
D O I：
10.1111/joim.13722
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：103 / 105
页数：3
相关论文
共 50 条
  • [31] ASSOCIATION BETWEEN SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT-2) INHIBITORS AND LOWER EXTREMITY AMPUTATION: A RETROSPECTIVE COHORT STUDY
    Chang, I. I.
    Singh, S.
    Mansour, O.
    Baksh, S.
    Alexander, G. C.
    VALUE IN HEALTH, 2018, 21 : S71 - S72
  • [32] Angiotensin receptor-neprilysin inhibitor and sodium-dependent glucose cotransporter-2 inhibitor-associated renal injury: a pharmacovigilance study
    Chen, Chen
    Wu, Bin
    Zhang, Chenyu
    Xu, Ting
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (03) : 259 - 266
  • [33] Increased risk of erythrocytosis in men with type 2 diabetes treated with combined sodium-glucose cotransporter-2 inhibitor and testosterone replacement therapy
    Gosmanov, A. R.
    Gemoets, D. E.
    Schumacher, K. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (10) : 2615 - 2621
  • [34] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
  • [35] Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
    Kalra, Sanjay
    Singh, Vikram
    Nagrale, Dinesh
    ADVANCES IN THERAPY, 2016, 33 (09) : 1502 - 1518
  • [36] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
    Heerspink, Hiddo J. L.
    Kosiborod, Mikhail
    Inzucchi, Silvio E.
    Cherney, David Z. I.
    KIDNEY INTERNATIONAL, 2018, 94 (01) : 26 - 39
  • [37] Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital
    Clark, Alexa
    Mohammed, Arifuddin Saad
    Raut, Amol
    Moore, Sarah
    Houlden, Robyn
    Awad, Sara
    CANADIAN JOURNAL OF DIABETES, 2021, 45 (03) : 214 - 219
  • [38] Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate Terminology
    Milder, Tamara Y.
    Milder, David A.
    Greenfield, Jerry R.
    Day, Richard O.
    DRUG SAFETY, 2023, 46 (12) : 1303 - 1305
  • [39] Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology
    Tamara Y. Milder
    David A. Milder
    Jerry R. Greenfield
    Richard O. Day
    Drug Safety, 2023, 46 : 1303 - 1305
  • [40] Sodium-glucose cotransporter-2 inhibitors: where and when?
    Cowie, Martin R.
    FUTURE CARDIOLOGY, 2020, 17 (03) : 403 - 406
12345